(Q74321718)
Statements
Phase I safety and pharmacokinetic studies of brequinar sodium after single ascending oral doses in stable renal, hepatic, and cardiac allograft recipients (English)
A S Joshi
S Y King
B A Zajac
L Makowka
L S Sher
B D Kahan
A H Menkis
C R Stiller
B Schaefle
D M Kornhauser
1 December 1997